Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 5/20 | 0.38 |
| ▸ | PI4KA | P42356 | 4/20 | 0.38 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.38 |
| ▸ | PIP5K1C | O60331 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | AXL | P30530 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17200317 | 0.76 | RAB9A (0.42) | SMN1; SMN2ALDH1A1MAPTTP53HSD17B10 | |
| SCHEMBL22993546 | 0.75 | ALDH1A1 (0.55) | SMN1; SMN2ALDH1A1MAPTPIK3CDPIK3CG | |
| SCHEMBL9676001 | 0.72 | PSMB8 (0.56) | SMN1; SMN2ALDH1A1MAPTHSD17B10RAB9A | |
| SCHEMBL2069631 | 0.72 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1MAPTPI4KAPI4KB | |
| SCHEMBL16835636 | 0.72 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1MAPTCYP3A4HSD17B10 | |
| SCHEMBL31726115 | 0.72 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1MAPTCYP3A4HSD17B10 | |
| SCHEMBL793886 | 0.71 | TYK2 (0.50) | SMN1; SMN2ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL793759 | 0.71 | TYK2 (0.47) | SMN1; SMN2ALDH1A1TP53CYP3A4HSD17B10 | |
| SCHEMBL21242832 | 0.71 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1MAPTCYP3A4HSD17B10 | |
| SCHEMBL34471500 | 0.71 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1MAPTCYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124205-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | DEWPOINT THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124205-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | CTNNB1, CTNNA1, CTNND1 | SMN1; SMN2 2898/4885ALDH1A1 1195/4885MAPT 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.